Clinical Trial Update: Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting safety and immunogenicity of the Rotavirus vaccine RotaTeq in infants with short bowel syndrome, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Children's Hospital of Michigan | Conditions: Short Bowel Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2014-06-13